• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环五肽内皮素拮抗剂的合成与构象分析

Synthesis and conformational analysis of cyclic pentapeptide endothelin antagonists.

作者信息

Lin M, Chan M F, Balaji V N, Castillo R S, Larive C K

机构信息

Department of Chemistry, University of Kansas, Lawrence, USA.

出版信息

Int J Pept Protein Res. 1996 Sep;48(3):229-39. doi: 10.1111/j.1399-3011.1996.tb00836.x.

DOI:10.1111/j.1399-3011.1996.tb00836.x
PMID:8897090
Abstract

Two endothelin antagonists cyclo(D-Leu-D-Val-Pro-D-Asp-Trp) (IPI-147), and cyclo (D-Trp-D-Asp-Ac3c-D-Val-Leu) (IPI-725) have been synthetized. Their solution conformations have been studied in aqueous solution by NMR spectroscopy and dynamics simulation. Activity studies show that IPI-725 is a strong ETA antagonist, while IPI-147 is a weak ETA antagonist. Comparison of the solution conformations of these two ETA antagonists suggests that the difference in their activities results from their structural differences. IPI-147 contains a type II beta-turn with a hydrogen bond between NH of D-Val and the C = O of D-Asp. IPI-725, on the other hand, contains two turns, a type II beta-turn with a hydrogen bond between NH of D-Asp and C = O of D-Val, as well as a gamma'-turn with a hydrogen bond formed between D-Val NH and D-Asp carbonyl group. Therefore IPI-147 appears to be more flexible than IPI-725. Although both beta-turns contain the same residues, their orders in the turn are reversed. The beta-turn in IPI-725 is formed with D-Val:Leu:D-Trp:D-Asp, while in IPI-147, the beta-turn is formed with D-Asp:Trp:D-Leu:D-Val. The activities and solution conformations of IPI-147 and IPI-725 were also compared with BQ-123 [cyclo(D-Trp-D-Asp-Pro-D-Val-Leu)], a well characterized, highly potent endothelin antagonist.

摘要

已合成了两种内皮素拮抗剂环(D-亮氨酸-D-缬氨酸-脯氨酸-D-天冬氨酸-色氨酸)(IPI-147)和环(D-色氨酸-D-天冬氨酸-Ac3c-D-缬氨酸-亮氨酸)(IPI-725)。通过核磁共振光谱和动力学模拟研究了它们在水溶液中的溶液构象。活性研究表明,IPI-725是一种强效的ETA拮抗剂,而IPI-147是一种弱ETA拮抗剂。比较这两种ETA拮抗剂的溶液构象表明,它们活性的差异源于其结构差异。IPI-147含有一个II型β-转角,在D-缬氨酸的NH与D-天冬氨酸的C=O之间存在氢键。另一方面,IPI-725含有两个转角,一个II型β-转角,在D-天冬氨酸的NH与D-缬氨酸的C=O之间存在氢键,以及一个γ'-转角,在D-缬氨酸NH与D-天冬氨酸羰基之间形成氢键。因此,IPI-147似乎比IPI-725更具柔性。尽管两个β-转角都包含相同的残基,但它们在转角中的顺序相反。IPI-725中的β-转角由D-缬氨酸:亮氨酸:D-色氨酸:D-天冬氨酸形成,而在IPI-147中,β-转角由D-天冬氨酸:色氨酸:D-亮氨酸:D-缬氨酸形成。还将IPI-147和IPI-725的活性和溶液构象与BQ-123[环(D-色氨酸-D-天冬氨酸-脯氨酸-D-缬氨酸-亮氨酸)]进行了比较,BQ-123是一种特征明确、高效的内皮素拮抗剂。

相似文献

1
Synthesis and conformational analysis of cyclic pentapeptide endothelin antagonists.环五肽内皮素拮抗剂的合成与构象分析
Int J Pept Protein Res. 1996 Sep;48(3):229-39. doi: 10.1111/j.1399-3011.1996.tb00836.x.
2
Rediscovering an endothelin antagonist (BQ-123): a self-deconvoluting cyclic pentapeptide library.重新发现一种内皮素拮抗剂(BQ - 123):一种自去卷积环五肽文库。
J Med Chem. 1996 Sep 13;39(19):3842-6. doi: 10.1021/jm9604078.
3
A conformational study by 1H NMR of a cyclic pentapeptide antagonist of endothelin.通过1H NMR对内皮素环状五肽拮抗剂进行的构象研究。
J Med Chem. 1993 Sep 3;36(18):2658-65. doi: 10.1021/jm00070a009.
4
Conformational study of cyclo[D-Trp-D-Asp-Pro-D-Val-Leu], an endothelin-A receptor-selective antagonist.内皮素-A受体选择性拮抗剂环[D-色氨酸-D-天冬氨酸-脯氨酸-D-缬氨酸-亮氨酸]的构象研究
FEBS Lett. 1992 Jan 13;296(1):1-6. doi: 10.1016/0014-5793(92)80390-3.
5
Solution conformation of a cyclic pentapeptide endothelin antagonist. Comparison of structures obtained from constrained dynamics and conformational search.一种环五肽内皮素拮抗剂的溶液构象。对通过受限动力学和构象搜索获得的结构进行比较。
FEBS Lett. 1992 Mar 16;299(3):255-61. doi: 10.1016/0014-5793(92)80127-3.
6
Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.基于异亮氨酸-亮氨酸-天冬氨酸-缬氨酸四肽的VLA-4(α4β1整合素)介导的细胞黏附的强效环状单体和二聚体肽抑制剂。
J Pept Sci. 2000 Jul;6(7):321-41. doi: 10.1002/1099-1387(200007)6:7<321::AID-PSC259>3.0.CO;2-A.
7
Multiple solution conformations of the integrin-binding cyclic pentapeptide cyclo(-Ser-D-Leu-Asp-Val-Pro-). Analysis of the (phi, psi) space available to cyclic pentapeptides.整合素结合环五肽环(-丝氨酸-D-亮氨酸-天冬氨酸-缬氨酸-脯氨酸-)的多种溶液构象。对环五肽可用的(φ,ψ)空间的分析。
Eur J Biochem. 1996 Dec 1;242(2):352-62. doi: 10.1111/j.1432-1033.1996.0352r.x.
8
Conformations of cyclic pentapeptide endothelin receptor antagonists.环五肽内皮素受体拮抗剂的构象
Int J Pept Protein Res. 1994 Sep;44(3):223-32. doi: 10.1111/j.1399-3011.1994.tb00164.x.
9
Design and synthesis of potent and selective alpha(4)beta(7) integrin antagonists.强效和选择性α4β7整合素拮抗剂的设计与合成
J Med Chem. 2001 Aug 2;44(16):2586-92. doi: 10.1021/jm0005508.
10
Synthesis and solution conformation of c(D-Trp-D-Cys(SO3-Na+)-Pro-D-Val-Leu), a potent endothelin-A receptor antagonist.强效内皮素-A受体拮抗剂c(D-色氨酸-D-半胱氨酸(磺酸钠)-脯氨酸-D-缬氨酸-亮氨酸)的合成与溶液构象
Int J Pept Protein Res. 1993 Aug;42(2):194-203. doi: 10.1111/j.1399-3011.1993.tb00496.x.